Registration is open for the 2024 ASRM Scientific Congress & Expo
Human embryonic aneuploidy may represent one of the final frontiers in assisted reproductive technology (ART), primarily secondary to oocyte aneuploidy. Mammalian oocytes possess unique
Programmed or medicated frozen embryo transfer cycles rely on exogenous progesterone (P) administration to prepare the endometrium for implantation and maintain pregnancy. Presently, the optimal
To compare in vitro fertilization treatment outcomes for the oral gonadotropin-releasing hormone (GnRH) antagonist elagolix (E) to the conventionally used injectable GnRH antagonist ganirelix (G)
To compare the morphokinetic patterns of human embryos originating from vitrified oocytes (VITRI group) with those derived from freshly collected oocytes (CONTROL group) in oocyte donation
To investigate whether artificial removal of zona-pellucida (ZP) at the pronuclear-stage improves good-quality embryos and blastocyst development in patients with difficulty conceiving due to
To compare cumulative live birth rate (CLBR) and cost-effectiveness of intracytoplasmic sperm injection (ICSI) vs. conventional in vitro fertilization (cIVF).
This issue of Fertility and Sterility Reports includes a contribution by Hristova et al. (1) regarding a potentially important alternate method for blastocyst vitrification. The technique
The World Health Organization reported recently that approximately 17.5% of couples worldwide experience infertility (1). This staggering number of 1 in 6 is the proportion of couples that will
To present the comprehensive methodology for generating personalized three-dimensional (3D) printed uterine models from 3D ultrasound (US) volumes in individuals diagnosed with Müllerian
To evaluate the efficacy and safety of 2 doses of vilaprisan vs. placebo in participants with symptomatic endometriosis.
Displaying 1 to 10 of 1660 records